A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation | Zendy

Monzr M. Al Malki | Zendy; NiChun Tsai | Zendy; Joycelynne Palmer | Zendy; Sally Mokhtari | Zendy; Thai M. Cao | Zendy; Haris Ali | Zendy; Amandeep Salhotra | Zendy; Shukaib Arslan | Zendy; Ibrahim Aldoss | Zendy; Nicole Karras | Zendy; Jasmine M. Zain | Zendy; Samer K. Khaled | Zendy; Anthony S. Stein | Zendy; David S. Snyder | Zendy; Guido Marcucci | Zendy; Stephen J. Forman | Zendy; Auayporn Nademanee | Zendy; Ryotaro Nakamura | Zendy

Open Access

A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Author(s) -

Monzr M. Al Malki,

NiChun Tsai,

Joycelynne Palmer,

Sally Mokhtari,

Thai M. Cao,

Haris Ali,

Amandeep Salhotra,

Shukaib Arslan,

Ibrahim Aldoss,

Nicole Karras,

Jasmine M. Zain,

Samer K. Khaled,

Anthony S. Stein,

David S. Snyder,

Guido Marcucci,

Stephen J. Forman,

Auayporn Nademanee,

Ryotaro Nakamura

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.752

Subject(s) - medicine , fludarabine , cyclophosphamide , transplantation , melphalan , graft versus host disease , tacrolimus , gastroenterology , mycophenolic acid , busulfan , hematopoietic stem cell transplantation , oncology , surgery , immunology , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research